News

NUH Singapore and X-ZELL agree on landmark cancer detection study

Singapore, June 2018 – The Department of Urology at Singapore’s National University Hospital and X-ZELL Inc. have signed a Letter of Intent (LOI) to jointly conduct a prospective, blinded study evaluating the utility of X-ZELL Prostate™ for early prostate cancer...

X-ZELL CEO reveals ground-breaking new microscopy method

Basel, June 2018 – Dr Sebastian Bhakdi, CEO of cancer detection start-up X-ZELL Inc., has outlined a ground-breaking new microscopy technique in the June edition of Methods & Protocols. In a bid to make the benefits of immunofluorescence staining more accessible in...

X-ZELL CEO reveals path to success in burgeoning biotech market

Singapore, May 2018 – X-ZELL CEO, Dr Sebastian Bhakdi, used his guest speaking spot at the 2018 HealthInvestor Asia Summit today to reflect on the opportunities and challenges biotechnology start-ups face in Asia and why so many of them fail to go all the way from...

X-ZELL launches new biotech blog

Singapore, May 2018 – X-ZELL Inc., one of Asia’s first Silicon Valley-backed biotech start-ups, has used today’s HealthInvestor Asia Summit in Singapore as a launch pad for a new biotech industry blog. According to X-ZELL CEO, Dr Sebastian Bhakdi, the blog will allow...

X-ZELL CEO to present at 2018 HealthInvestor Asia Summit

Singapore, March 2018 – X-ZELL Inc. is proud to confirm a special presentation by company CEO, Dr Sebastian Chakrit Bhakdi, at the 2018 HealthInvestor Asia Summit in Singapore on 15 May 2018. The TED-style presentation will give attendees a world-exclusive first look...

Prominent Thai physician comes out in support of X-ZELL Inc. agenda

Bangkok, January 2018 – Prof Dr Pornchai O-Charoenrat, Chief of the Department of Head, Neck and Breast Surgery at Mahidol University’s Siriraj, has come out in support of X-ZELL Inc.’s groundbreaking research in the cancer detection space. Echoing X-ZELL Inc. CEO Dr...

Is early cancer detection closer than we think?

  Sunnyvale/ Bangkok, January 2018 – Dr Sebastian Chakrit Bhakdi, CEO of up-and-coming biotech start-up, X-ZELL Inc., has commended the research team behind Johns Hopkins’ University’s CancerSeek study on advancing the public debate around early cancer detection....

X-ZELL Inc. gearing up for biggest year yet

  Sunnyvale/ Bangkok, January 2018 – Following a “wildly successful” final quarter of 2017, X-ZELL Inc. CEO, Dr Sebastian Chakrit Punyaratabandhu Bhakdi, is confident that 2018 will be the rare cell detection start-up’s biggest year yet. “X-ZELL Inc. has made...

เครื่องมือวินิจฉัยใหม่สำหรับผู้ป่วยโรคมะเร็งต่อมลูกหมากในประเทศไทย

  Bangkok, December 2560 – บริษัทเอ็กซ์-เซลล์ เป็นบริษัทด้าน เทคโนโลยีชีวภาพระดับนานาชาติที่เชี่ยวชาญในเทคโนโลยีการตรวจหาเซลล์ที่หายาก ซึ่งกำลังเปิดตัวชุดทดสอบมะเร็งต่อมลูกหมากแบบใหม่ในประเทศไทย ผลิตภัณฑ์ภายใต้ชื่อ X-ZELL Prostate™ จะวางจำหน่ายตั้งแต่วันที่ 5 ธันวาคม...

X-ZELL Prostate™ now available in Thailand

  Bangkok, December 2017 – X-ZELL, a global biotech firm specialising in rare cell detection technology, is launching a revolutionary new prostate cancer test in the Kingdom of Thailand. The test – aptly named X-ZELL Prostate™ – will be available from 5 December 2017...

Get in Touch

Use the form below to contact us for more information.

X-ZELL

FIGHTING CANCER,
ONE CELL AT A TIME.

© 2018 X-ZELL INC

Find Us

XZELL HQ